Title: Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.
Journal: Scientific reports 20180101
10015-68-6
1159824-79-9
126127-31-9
1219182-45-2
142128-47-0
14429-43-7
147762-53-6 | Fmoc-o-phospho-l-tyrosine | AA001F3Z | MFCD00235902
1481-63-6 | 1-Bromo-2,4-dichloro-5-fluorobenzene | AA001FDJ | MFCD06659468
141-63-9 | Dodecamethylpentasiloxane | AA001FNP | MFCD00039795
141452-01-9 | Methyl indoline-5-carboxylate | AA001GBQ | MFCD07371630
1416439-55-8 | 5-Chloroquinoline-3-carboxylic acid | AA001GPI | MFCD22690552
1418117-73-3 | Ethyl 3-(4-Methyl-2,5-dioxo-4-imidazolidinyl)propanoate | AA001H5I | MFCD22682790
14205-39-1 | Methyl 3-aminobut-2-enoate | AA001HKT | MFCD00008072
142253-54-1 | 1-Boc-3-cyanoazetidine | AA001HZM | MFCD06796640
143884-84-8 | 7-Fluoro-3-(hydroxyimino)indolin-2-one | AA001IHO | MFCD02951896
1441673-92-2 | (6S)-5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid 5-(1,1-dimethylethyl) ester potassium salt | AA001IY8 | MFCD28385907